Abstract: Use of the proprietary drug amiloride for the treatment of cancer types that depend on an enzymatic cascade triggered by the activation of plasminogen to plasmin by the specific activating enzyme Urokinase Plasminogen Activator (uPA). Administration of amiloride inhibits the action of uPA, inhibits the ability of the cancer cell to attract new blood supply, blocks the Na+/H+ transporter, and inhibits ornithine decarboxylase necessary for DNA synthesis. Further, in combination with amiloride, a different step in the enzymatic cascade is targeted by a secondary agent, Batimistat, for example, which is a metalloprotease inhibitor. Additionally, the use of hydrochlorothiazide promotes excretion of potassium.

Abstract: A protective pad to be placed to protect a part of a person's body from injury due to impacts includes two layers of foamed polyethylene spaced a distance apart from each other and a layer of foamed polystyrene granules interposed between the two polyethylene layers. Also included is a garment for securing the protective pad in a position adjacent the part of the person's body subject to injury from impact. The securing apparatus may be a hip garment to protect the hips of a wearer that includes a piece of fabric to fit around the hips of the wearer and pockets attached to the fabric, the pockets holding the protective pad. The protective pad may also be used in a chest garment to protect the chest of a wearer.